COVID-19 Severity: Lung-Heart Interplay

Gayatri Puri1, Vikram P Singh2, Amarjit S Naura1

  • 1Department of Biochemistry, Panjab University, Chandigarh 160014, India.

Current Cardiology Reviews
|December 11, 2020
PubMed

Insights

Severe COVID-19 (coronavirus disease 2019) can cause lung failure and heart damage. Understanding the lung-heart connection is crucial for developing effective treatments and improving patient outcomes.

Area of Science:

  • Cardiology
  • Pulmonology
  • Infectious Diseases

Background:

  • COVID-19, caused by SARS-CoV-2, emerged globally in late 2019, causing widespread illness and mortality.
  • The virus primarily targets the pulmonary system, potentially leading to Acute Respiratory Distress Syndrome (ARDS) and lung failure.
  • Co-morbidities like cardiovascular disease and diabetes are linked to increased COVID-19 severity, with myocardial injury observed even in patients without prior heart conditions.

Purpose of the Study:

  • To explore the intricate relationship between lung and heart function during SARS-CoV-2 infection.
  • To elucidate the mechanisms underlying the observed lung-heart crosstalk in COVID-19 patients.
  • To provide insights for developing effective diagnostic and therapeutic strategies to mitigate COVID-19 severity.

Main Methods:

  • This review synthesizes current scientific literature on COVID-19 pathophysiology.
  • It analyzes mechanisms of pulmonary damage and secondary cardiac complications.
  • The focus is on understanding the interplay between respiratory and cardiovascular systems.

Main Results:

  • SARS-CoV-2 infection can trigger significant pulmonary inflammation, leading to systemic effects.
  • Pulmonary damage can precipitate myocardial injury, even in individuals without pre-existing cardiovascular conditions.
  • The crosstalk between lung and heart contributes to the high mortality rates observed in severe COVID-19 cases.

Conclusions:

  • Understanding the lung-heart axis in COVID-19 is essential for early diagnosis and risk stratification.
  • Identifying these mechanisms can guide the development of targeted treatments to reduce disease severity and mortality.
  • Further research into this crosstalk may reveal novel therapeutic targets for managing severe COVID-19.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
640
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.2K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
435